Jesse W. Keller

Jesse W. Keller's research delves into the intricate world of clinical outcomes in melanoma and skin cancers, with a keen focus on novel therapies and immunotherapy. As an Assistant Professor of Medicine in the Division of Oncology at Washington University School of Medicine, Dr. Keller brings a wealth of knowledge and expertise to the field of medical oncology. His specialization in melanoma and nonmelanoma skin cancers positions him as a leading figure in the development and application of cutting-edge treatments. Dr. Keller is board-certified in both Medical Oncology and Internal Medicine, underscoring his comprehensive understanding of cancer treatment and patient care. His clinical practice is based at the Barnes-Jewish West County Hospital – Siteman Cancer Center Medical Office Building 2, where he is dedicated to providing exceptional care to his patients. His commitment to advancing the field of oncology is evident in his research pursuits, which aim to improve clinical outcomes and develop innovative therapies for skin cancer patients. In addition to his clinical work, Dr. Keller is actively involved in research that seeks to unravel the complexities of melanoma and skin cancers. His interest in immunotherapy highlights his dedication to exploring new avenues for treatment that harness the body's immune system to combat cancer. Through his research, Dr. Keller strives to contribute to the growing body of knowledge that will ultimately lead to more effective and personalized treatment options for patients. Dr. Keller's work is characterized by a deep commitment to improving patient outcomes and advancing the field of oncology. His research not only focuses on the development of novel therapies but also on understanding the factors that influence clinical outcomes in melanoma and skin cancers. By bridging the gap between research and clinical practice, Dr. Keller is at the forefront of efforts to enhance the quality of care for cancer patients. As a respected member of the academic and medical communities, Dr. Keller continues to contribute to the advancement of oncology through his research, clinical practice, and dedication to patient care. His work is instrumental in shaping the future of cancer treatment, particularly in the realm of skin cancers and melanoma.